scispace - formally typeset
Open AccessJournal ArticleDOI

Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.

Reads0
Chats0
TLDR
It is demonstrated that eosinophils can protect against RSV in vivo, as they promote virus clearance and may thus limit virus-induced lung dysfunction.
About
This article is published in Blood.The article was published on 2007-09-01 and is currently open access. It has received 249 citations till now. The article focuses on the topics: Virus & Interleukin 5.

read more

Figures
Citations
More filters
Journal ArticleDOI

Eosinophils: Biological Properties and Role in Health and Disease

TL;DR: The biology of eosinophils is summarized, focusing on transcriptional regulation of eOSinophil differentiation, characterization of the growing properties of eOsinophIL granule proteins, surface proteins and pleiotropic mediators, and molecular mechanisms of Eosinophile degranulation.
Journal ArticleDOI

Eosinophils: changing perspectives in health and disease

TL;DR: New insights into the molecular pathways that control the development, trafficking and degranulation of eosinophils have improved the understanding of the immunomodulatory functions of these cells and their roles in promoting homeostasis.
Journal ArticleDOI

Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis

TL;DR: Human respiratory syncytial virus (RSV) was first isolated in 1956 from a laboratory chimpanzee with upper respiratory tract disease and was quickly determined to be of human origin and was shown to be the leading virus.
Journal ArticleDOI

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

TL;DR: RSV is notable for a historic, tragic pediatric vaccine failure involving a formalin-inactivated virus preparation that was evaluated in the 1960s and that was poorly protective and paradoxically primed for enhanced RSV disease.
Journal ArticleDOI

The role of viruses in acute exacerbations of asthma.

TL;DR: The role of the bronchial epithelium as well as the main inflammatory cells, mediators, and molecular pathways that are involved in the immune response are examined, examining the potential impact of virus-induced asthma exacerbations on airway remodelling.
References
More filters
Journal ArticleDOI

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

TL;DR: It is shown that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-κB and the production of type I interferons (IFNs).
Journal ArticleDOI

Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8

TL;DR: It is shown that guanosine (G)- and uridine (U)-rich ssRNA oligonucleotides derived from human immunodeficiency virus–1 (HIV-1) stimulate dendritic cells and macrophages to secrete interferon-α and proinflammatory, as well as regulatory, cytokines, and these data suggest that ssRNA represents a physiological ligand for TLR7 and TLR8.
Journal ArticleDOI

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.

TL;DR: These results identify ssRNA as a ligand for TLR7 and suggest that cells of the innate immune system sense endosomal ssRNA to detect infection by RNA viruses.
Journal ArticleDOI

IRF-7 is the master regulator of type-I interferon-dependent immune responses

TL;DR: It is shown that mice deficient in the Irf7 gene are more vulnerable than Myd88-/- mice to viral infection, and this correlates with a marked decrease in serum IFN levels, indicating the importance of the IRF-7-dependent induction of systemic IFN responses for innate antiviral immunity.
Journal ArticleDOI

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

TL;DR: Results indicate that l‐NMMA, l‐NIO and l‐NAME are inhibitors of NO synthase in the vascular endothelium and confirm the important role of NO synthesis in the maintenance of vascular tone and blood pressure.
Related Papers (5)
Frequently Asked Questions (15)
Q1. What contributions have the authors mentioned in the paper "Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus author" ?

In this paper, the role of eosinophils in immunity against infectious pathogens was investigated, and it was shown that eosINophils contribute to host defense or to the immunopathology observed in response to RSV infection. 

Eosinophil NO production contributes to antiviral immunity from RSVNitric oxide (NO) has been implicated in antiviral host defense and may also be functionally protective through bronchodilatory mechanisms. 

The immediate response to RSV infection in immunocompetent hosts includes recruitment of proinflammatory granulocytes, which themselves express TLRs. 

Eosinophil transfer reduces AHR in RSV-infected miceBecause RSV infection has been associated with AHR, the authors next examined whether eosinophil-mediated viral clearance could suppress RSV-induced AHR. 

Eosinophils directly transferred into the airways have been shown to remain functional and can migrate into the lung and local pulmonary lymph nodes, where they actively participate in immune responses. 

it is likely that the role ofeosinophils in the modulation of immune or pathologic processes is highly dependent on signals received from the microenvironment and signals that are associated with specific inflammatory responses. 

the authors show that eosinophil-mediated accelerated RSV clearance and attenuated lung dysfunction are dependent on the TIR adaptor molecule MyD88 and the production of NO by NOS-2.TLRs are a conserved family of PRRs that bridge innate pathogen recognition and the development of adaptive (T and B lymphocyte) immune responses. 

In the setting of allergic asthma, where eosinophils are prevalent in the airway mucosa and exacerbations of disease are most frequently caused by viral infections, eosinophils have often been implicated as a causative agent of AHR.49-51 

RSV infection resulted in an increase in the number of goblet cells secreting mucus into the airways in both hypereosinophilic and WT mice within 24 hours (data not shown). 

L-NMA significantly delayed the clearance of RSV in WT mice, and completely reversed the advantage conferred by the hypereosinophilic status of IL-5 Tg mice (Figure 5C). 

To confirm that accelerated virus clearance was due specifically to eosinophils and not the overexpression of IL-5, the authors FACSpurified eosinophils ( 98% pure) from the spleens of hypereosinophilic mice, and performed an adoptive transfer directly into the lungs of WT mice 2 hours before RSV inoculation. 

To demonstrate that eosinophils confer protection from RSV, the authors used dblGATA mice, whose eosinophil lineage is selectively and severely disrupted. 

Eosinophils recovered by FACS (BD Biosciences FACS Vantage Diva) were approximately 99% pure as determined by Giemsa-stained cytospin preparations. 

In the mouse, the authors demonstrate at the protein level that eosinophils express another TLR that can recognize molecular patterns expressed by RSV, namely TLR-7. 

Having demonstrated that RSV induces systemic effects, the authors next determined if antiviral genes were induced in eosinophils in response to infection.